METHOTREXATE, VIALS 3 Serious Warnings and Precautions Box

methotrexate, vials

(

Serious Warnings and Precautions 

  • Methotrexate Injection USP should be used only by physicians whose knowledge and experience includes the use of antimetabolite therapy because of the possibility of serious toxic reactions (see 7 WARNINGS AND PRECAUTIONS: General). 
  • Methotrexate Injection USP formulations which contain benzyl alcohol are contraindicated in neonates and for intrathecal, intracerebroventricular, or high dose therapy (see 2 CONTRAINDICATIONS).
  • Methotrexate has been reported to cause fetal death and/or congenital anomalies (see 7.1.1 Pregnant Women). Therefore, use is contraindicated for women of childbearing potential until pregnancy is excluded and pregnant patients with psoriasis or rheumatoid arthritis (see 2 CONTRAINDICATIONS).
)

Find METHOTREXATE, VIALS medical information:

Find METHOTREXATE, VIALS medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

METHOTREXATE, VIALS Quick Finder

Product Monograph
Download Product Monograph

Health Professional Information

3 Serious Warnings and Precautions Box

Serious Warnings and Precautions 

  • Methotrexate Injection USP should be used only by physicians whose knowledge and experience includes the use of antimetabolite therapy because of the possibility of serious toxic reactions (see 7 WARNINGS AND PRECAUTIONS: General). 
  • Methotrexate Injection USP formulations which contain benzyl alcohol are contraindicated in neonates and for intrathecal, intracerebroventricular, or high dose therapy (see 2 CONTRAINDICATIONS).
  • Methotrexate has been reported to cause fetal death and/or congenital anomalies (see 7.1.1 Pregnant Women). Therefore, use is contraindicated for women of childbearing potential until pregnancy is excluded and pregnant patients with psoriasis or rheumatoid arthritis (see 2 CONTRAINDICATIONS).

Resources

Didn’t find what you were looking for? 

Contact us

Call 1-800-463-6001*

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product:

Canada Vigilance Program 

You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect.